To determine the role of CYP1B1 in the gender difference in response to Ang II-induced hypertension, female Cyp1b1+/+ and Cyp1b1−/− mice were infused with Ang II (700 ng/kg/min) or vehicle with/without ovariectomy. In addition, mice were treated with the CYP1B1 inhibitor, 2,3′,4,5′-tetramethoxystilbene (TMS, 300 μg/kg, every 3rd day, i.p.), and 17-β-estradiol metabolites, 2-hydroxyestradiol (2-OHE), 4-OHE, or 2-methoxyestradiol (2-MeE2) (1.5 mg/kg/day, i.p., for 2 weeks), and systolic blood pressure (SBP) measured. Ang II increased SBP more in Cyp1b1−/− than in Cyp1b1+/+ mice (119±3 to 171±11 mmHg vs. 120±4 to 149±4 mmHg, P<0.05). Ang II caused cardiovascular remodeling and endothelial dysfunction, and increased vascular reactivity and oxidative stress in Cyp1b1−/− but not Cyp1b1+/+mice. The Ang II-induced increase in SBP was enhanced by ovariectomy and TMS in Cyp1b1+/+ but not Cyp1b1−/− mice. 2-OHE did not alter Ang II-induced increase in SBP in Cyp1b1+/+ mice but minimized it in Cyp1b1−/− mice, whereas 4-OHE enhanced Ang II-induced increase in SBP in Cyp1b1+/+ mice but did not alter the increased SBP in Cyp1b1−/− mice. 2-OHE-derived catechol-O-methyltransferase metabolite, 2-MeE2, inhibited Ang II-induced increase in SBP in Cyp1b1−/− mice. Ang II increased plasma levels of 2MeE2 in Cyp1b1+/+ but not Cyp1b1−/− mice, and increased activity of cardiac extracellular signal-regulated kinase 1/2, p38 mitogen-activated kinase, c-Src, and Akt in Cyp1b1−/− but not Cyp1b1+/+ mice. These data suggest that CYP1B1 protects against Ang II-induced hypertension and associated cardiovascular changes in female mice, most likely mediated by 2-MeE2-inhibiting oxidative stress and the activity of these signaling molecules.